Day: October 27, 2021
Trial Will Evaluate Progesterone Receptor ONA-XR in Combination with Estrogen Receptor Antagonist to Determine Potential of Complete Hormone Blockade on Metastatic Breast Cancer Outcomes
PHILADELPHIA, Oct. 27, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (Nasdaq: CNTX), a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers, and Wisconsin Oncology Network (WON), today announced the first patient has been dosed in the Phase 2 Trial of OnapriStone in CoMbInation with FuLvestrant for Patients with ER-positive, and HER2-negative Metastatic Breast Cancer after Progression on Endocrine therapy and CDK 4/6 Inhibitors (The SMILE Study).
The single-arm trial conducted by the WON will evaluate the effect of progesterone receptor...
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin
Written by Customer Service on . Posted in Public Companies.
Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use
DENVER, Oct. 27, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced that it has successfully synthesized a novel psilocin analogue with improved pharmaceutical properties to further expand its library of patent-pending tryptamines.
The synthesis of this novel psilocin analogue, a tryptamine, is the newest compound to be added to Mydecine’s growing library of patent-pending compounds. The inclusion of this compound supports and builds upon Mydecine’s...
Stock Yards Bancorp Reports Strong Third Quarter Earnings of $23.2 Million or $0.86 Per Diluted Share
Written by Customer Service on . Posted in Public Companies.
Third Quarter Highlighted by Solid Organic Loan Growth and Record Levels of Operating Income
LOUISVILLE, Ky., Oct. 27, 2021 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, Central and Eastern Kentucky, as well as the Indianapolis and Cincinnati metropolitan markets, today reported earnings for the third quarter ended September 30, 2021. Net income for the third quarter was $23.2 million, or $0.86 per diluted share, compared with net income of $14.5 million, or $0.64 per diluted share, for the third quarter of 2020. Strong organic loan growth across all markets and record levels of operating (non-interest) income highlighted by wealth management and trust, card income and treasury management fees, contributed to strong profitability...
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
Written by Customer Service on . Posted in Public Companies.
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.
The orders translate to 20,000 tests – while modest in size, the order is expected to pave the way to rapid adoption by other locations and countries.
After consolidating the results of the first sales, the pilot project, and the data from the first production, the platform will be quickly scaled and supplemented with additional products.
Following the receipt of the CE marking, the expansion into further countries will be initiated.ZURICH, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR – On the heels of its announcements regarding a commercial pilot in Indonesia and initial production planning, Achiko AG (SWX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) is proud to announce that it has successfully...
Midland Issues an Update on Its Activities in Quebec and Identifies Several New Exploration Targets
Written by Customer Service on . Posted in Public Companies.
Figure 1Abitibi Geology – Midland ProjectsFigure 2Midland-Wallbridge Casault OptionFigure 3Casault Option – Property GeologyFigure 4Casault Option – 1st Magnetic DerivativeFigure 5Lewis Project – Golden Nest New ShowingFigure 6Lewis Project – Golden Nest Sample A0358475Figure 7Lewis Project – Golden Nest Sample A0361223Figure 8Lewis Project-Golden Nest New ChannelFigure 9James Bay Geology – Midland ProjectsFigure 10Mythril Regional – New Results OverviewFigure 11Chisaayuu Project- New Results OverviewFigure 12Chisaayuu Project – New Au-Ag-Cu-Mo FloatsFigure 13Galinee Project...
CloudMD Receives U.S. Patent Approval for its Proprietary Real Time Intervention Platform (RTIP)
Written by Customer Service on . Posted in Public Companies.
This platform is the technology that supports interoperability and provides the integration of all of CloudMD’s healthcare capabilities
Platform is trusted by various local, state and federal agencies including the U.S. Department of Justice and U.S Department of Health and Human Services
RTIP will power the Company’s data warehouse to support real time analytics, data and outcomes
One of five companies awarded a six year contract by the State of Nebraska to assist in the modernization of Health and Human Service systemsVANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company transforming the delivery of care, is pleased to announce that through its subsidiary, IDYA4 LLC., it has...
ParcelPal Publishes Updated Corporate Presentation and Provides Operations Update
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) — ParcelPal Logistics Inc. (the “Company” or “ParcelPal”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce that is has published its updated Company presentation on its website at www.parcelpal.com. The Company’s presentation includes, among other things, additional information on the Company’s recent US acquisition, future expansion plans, as well as information regarding other positive developments in the Company.
CEO Rich Wheeless commented, “I am very pleased and encouraged by the continued improvement in operating performance, our revenue growth, and most importantly, our recent expansion into the United States. The U.S. acquisition not only nearly doubles the size of the Company on a revenue basis, but it gives us a footprint in the western U.S....
Algoma Announces Retirement of Chief Commercial Officer
Written by Customer Service on . Posted in Public Companies.
SAULT STE. MARIE, Ontario, Oct. 27, 2021 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (“Algoma”) (NASDAQ: ASTL; TSX: ASTL), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today announced its Chief Commercial Officer Robert Dionisi, has indicated his pending retirement effective May 1st, 2022. The Company has identified Rory Brandow, Algoma’s current Director of Regional Sales to succeed Robert as Vice President of Sales.
Algoma Chief Executive Officer Michael McQuade remarked, “Over a rich, 42-year career with Algoma Rob has exemplified Algoma’s trademark mantra, ‘Your Partner in Steel’ building strong and lasting relationships with customers across a multitude of markets and geographies. His passion for quality service has been internalized by our entire commercial team and we extend our sincere...
Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021
Written by Customer Service on . Posted in Public Companies.
PARSIPPANY, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Wednesday, November 3, 2021. Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.
To participate in the conference call, dial 1-877-845-0779 and provide the passcode 5562638. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com.
For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode...
Werewolf Therapeutics to Present Data on its INDUKINE™ Product Candidates at the Society for Immunotherapy of Cancer Annual Meeting
Written by Customer Service on . Posted in Public Companies.
Posters Detail Preclinical Data on the Company’s WTX-124 and WTX-330 Molecules for the Potential Treatment of Cancer
CAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that it will present preclinical data at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) being held November 10-14, 2021, in Washington, D.C., and virtually.
“We are excited to share additional preclinical data demonstrating the potential of our INDUKINE™ molecules to drive targeted anti-tumor immune responses with IL-2 and IL-12 cytokines, as well as interferon alpha,” said Cynthia Seidel-Dugan,...